2002
DOI: 10.1097/00005537-200202000-00036
|View full text |Cite
|
Sign up to set email alerts
|

Association Between High Initial Tissue Levels of Cyclin D1 and Recurrence of Nasopharyngeal Carcinoma

Abstract: The present study demonstrates that cyclin D1 can be used as an indicator of recurrence and subsequent prognosis in nasopharyngeal carcinoma after radiation therapy. At the same time, the apoptotic state before radiation therapy is of no value in predicting the prognosis of patients with nasopharyngeal carcinoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
16
2

Year Published

2003
2003
2014
2014

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(19 citation statements)
references
References 30 publications
1
16
2
Order By: Relevance
“…recurrent NPC specimens found in this study (26%) was not higher, but slightly lower than those reported for previously untreated NPC (30% to 66%) [7,9,18].…”
Section: Kaplan-meier Survival Curvecontrasting
confidence: 83%
“…recurrent NPC specimens found in this study (26%) was not higher, but slightly lower than those reported for previously untreated NPC (30% to 66%) [7,9,18].…”
Section: Kaplan-meier Survival Curvecontrasting
confidence: 83%
“…Moreover, particular attention should be paid to the differences in histological types, ethnic composition and stage distribution, since treatment results may differ in function of these characteristics [10,61]. Optimal choice of treatment might be further facilitated by a better understanding of the biology of nasopharyngeal cancers [19,32].…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies revealed that elevated levels of cyclin D1 confer radiation resistance of cancer cells (29,30) and high levels of cyclin D1 correlate with unfavorable response to radiotherapy (31,32). Conversely, suppression of cyclin D1 sensitizes cancer cells to DNA damage (29,33).…”
Section: P16ink4a Inhibits Recruitment Of Rad51 To the Sites Of Dna Dmentioning
confidence: 99%